Inograft Biotherapeutics

Inograft

Inograft Biotherapeutics was founded in 2022, is headquartered in Redwood City, United States, lists 11–50 employees, and has 1 recorded funding round.

Employees
11–50
Founded
2022
Business Model
B2B
Rounds
1

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Inograft Biotherapeutics develops targeted biologic conditioning therapies intended to make hematopoietic stem-cell transplantation safer and more precise. Its approach uses antibody-based, non-genotoxic conditioning to replace chemotherapy and radiation, which can damage healthy tissue and limit access to transplantation. The company uses research and predictive preclinical models to identify cellular and immune barriers to engraftment and advance therapies for blood and immune-system regeneration.

Summary

Inograft Biotherapeutics is a Biotech company based in Redwood City, United States, founded in 2022. It lists 11–50 employees. Investors include ARCH Venture Partners, Frazier Life Sciences and Sutter Hill.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed Round

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Inograft Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/inograft-biotherapeutics"><img src="https://indexed.vc/api/badge/company/inograft-biotherapeutics" alt="Inograft Biotherapeutics on Indexed.vc" width="260" height="76" /></a>